EXL.AU · Elixinol Global Limited

-

Please sign in to comment on EXL.AU

1 Comment

Admin

4 years, 12 months ago

Elixinol Global Limited is currently in a long term downtrend where the price is trading 27.1% below its 200 day moving average.

From a valuation standpoint, the stock is 98.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.9.

Elixinol Global Limited's total revenue sank by 28.3% to $7M since the same quarter in the previous year.

Its net income has increased by 68.7% to $-23M since the same quarter in the previous year.

Finally, its free cash flow grew by 79.7% to $-4M since the same quarter in the previous year.

Based on the above factors, Elixinol Global Limited gets an overall score of 3/5.

ISIN	AU000000EXL4
Exchange	AU
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
CurrencyCode	AUD

Market Cap	3M
Beta	2.28
PE Ratio	None
Target Price	0.03
Dividend Yield	None

ABOUT

Elixinol Global Limited

Elixinol Wellness Limited, a holding company, produces and sells human nutrition, human wellness, pet wellness, and superfood ingredients in Australia, the Americas, and internationally. The company offers its products under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributes its products through grocery, wholesale, and e-commerce channels for white label customers, as well as food, beverage, and beauty manufacturers. In addition, the company engages in the manufacture and distribution of hemp-derived cannabidiol (CBD) products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is based in Newtown, Australia.

EXL.AU · Elixinol Global Limited

-

Elixinol Global Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Elixinol Global Limited using a moving average strategy